A Randomized Phase 4 Study Comparing 2 Intravenous Temsirolimus (Temsr) Regimens In Subjects With Relapsed, Refractory Mantle Cell Lymphoma
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 12 Jul 2018
At a glance
- Drugs Temsirolimus (Primary) ; Desipramine
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
- Sponsors Pfizer
- 07 Jul 2018 This trial has been completed in France.
- 24 May 2018 This trial has been completed in Czech Republic.
- 11 Apr 2017 Planned End Date changed from 1 Oct 2017 to 15 Jun 2018.